{
  "docId": "019dd923-5ca1-7489-b636-bc879d1b6d64",
  "docSlug": "17680cec2cbd3510",
  "documentTitle": "Accelerated Access Review UK Mapping",
  "authorId": "Deloitte",
  "authorName": "Deloitte",
  "documentKindSlug": "consulting-deck",
  "documentKindLabel": "Consulting deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.333,
  "pageNumber": 5,
  "pageCount": 109,
  "prevPage": 4,
  "nextPage": 6,
  "slideType": "problem_statement",
  "function": "frame_problem",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "The slide uses a two-part framework to categorize challenges, distinguishing between systemic/cross-cutting issues and those specific to certain sectors (pharma, devices, diagnostics) or pathway stages.",
  "elementsJson": [
    "headline_text",
    "subtitle_text",
    "process_diagram",
    "icon_grid"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5ca1-7489-b636-bc879d1b6d64/5",
  "deckHref": "/decks/019dd923-5ca1-7489-b636-bc879d1b6d64",
  "deckJsonHref": "/decks/019dd923-5ca1-7489-b636-bc879d1b6d64.json",
  "deckAnchorHref": "/decks/019dd923-5ca1-7489-b636-bc879d1b6d64#slide-5",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "Throughout this report we consider two sets of access challenges for innovative pharmaceuticals, medical devices and in vitro diagnostics.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd951-ba8c-7422-853a-70911f01e6e6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.54,
        "x": 0.24,
        "y": 0.26
      },
      "kind": "diagram",
      "text": "Cross-cutting challenges diagram showing alignment, incentives, data, and culture across development, regulation, reimbursement, and adoption.",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "64c18f76-3016-47f8-b24d-2f425fbf204d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.54,
        "x": 0.24,
        "y": 0.57
      },
      "kind": "diagram",
      "text": "Sector & pathway-specific challenges diagram showing detailed issues across the four stages for different sectors.",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "77db7fac-2120-4ff2-90e9-de33f4564d64",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.85,
        "x": 0.04,
        "y": 0.11
      },
      "kind": "paragraph",
      "text": "Throughout this report we consider two sets of access challenges for innovative pharmaceuticals, medical devices and in vitro diagnostics",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a5555fe8-a759-4124-9894-973f474caf64",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.3,
        "x": 0.04,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "Source: Stakeholder interviews, workshops and Deloitte analysis",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a3e2a890-0f7b-4eac-b3cc-15767dba36a5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.45,
        "x": 0.04,
        "y": 0.04
      },
      "kind": "title",
      "text": "Challenges to early access",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f38d48f1-091b-4b94-abc0-62de3ab860be",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Problem Statement Canvas",
      "slug": "problem-statement-canvas",
      "agent": "Architect",
      "layer": "slide",
      "matchId": "95a619b1-e566-4890-85a1-0cf6764f15b0",
      "evidence": "The text mentions 'two sets of access challenges for innovative pharmaceuticals, medical devices and in vitro diagnostics'.",
      "confidence": 0.7
    }
  ],
  "frameworks": [
    {
      "name": "problem-statement",
      "slug": null,
      "matchId": "a934f4e6-56d4-4887-9db3-791ab75ca3e7",
      "evidence": "Categorization of challenges into cross-cutting vs specific",
      "confidence": 0.8
    }
  ],
  "arcBeats": [
    {
      "to": 9,
      "from": 5,
      "beatId": "0a043aaa-9d86-481c-b01c-e99e57aaaa1e",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Problem (Identify pain)",
      "beatSlug": "problem-agitate-solution-problem-identify-pain",
      "evidence": "The document identifies key challenges in pharmaceuticals, medical devices, and in vitro diagnostics.",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [
    {
      "to": 20,
      "from": 5,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "216c31e8-2aee-4a6b-81ea-25d4d04ac422",
      "evidence": "The document highlights the consequences of not addressing the challenges, such as limited access to new treatments and technologies.",
      "position": 0,
      "objective": "What are the consequences of not improving access to medical innovations?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.7,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}